Form 8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 


FORM 8-K

 


CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF

THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of Earliest Event Reported): October 31, 2007

 


THE CLOROX COMPANY

(Exact name of registrant as specified in its charter)

 


Delaware

(State or other jurisdiction of incorporation or organization)

 

1-07151   31-0595760
(Commission File Number)   (I.R.S. Employer Identification No.)

1221 Broadway, Oakland, California 94612-1888

(Address of principal executive offices) (Zip code)

(510) 271-7000

(Registrant’s telephone number, including area code)

 

(Former name or former address, if changed since last report)

 


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2.)

 

¨ Written communications pursuant to Rule 425 Under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 



Item 2.02 Results of Operations and Financial Condition

On October 31, 2007, The Clorox Company (the “Company”) issued a press release announcing its financial results for its fiscal quarter ended September 30, 2007. The full text of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

 

Item 7.01 Regulation FD

Attached hereto as Exhibit 99.2 and incorporated herein by reference is supplemental financial information regarding the Company’s financial results for its fiscal quarter ended September 30, 2007.

On October 31, 2007, the Company announced that it will acquire Burt’s Bees, a leader in the natural personal care category. The full text of the press release related to the acquisition is attached hereto as Exhibit 99.3 and is incorporated herein by reference. Supplemental information regarding the acquisition is attached hereto as Exhibit 99.4 and is incorporated herein by reference.

 

Item 9.01 Financial Statements and Exhibits

 

  (c) Exhibits

 

Exhibit  

Description

99.1   Press Release dated October 31, 2007 of The Clorox Company announcing financial results for the quarter ended September 30, 2007
99.2   Supplemental information regarding financial results
99.3   Press Release dated October 31, 2007 of The Clorox Company announcing acquisition agreement
99.4   Supplemental information regarding acquisition


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  THE CLOROX COMPANY
Date: October 31, 2007    
  By:  

/s/ Laura Stein

    Senior Vice President – General Counsel